Hemostatic Disorders: Clinical Trials

15 trials for Hemostatic Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 unknown. 15 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 415Unknown 15

Follow Hemostatic Disorders: new trials by email Literature Review of Hemostatic Disorders trials Research Report on Hemostatic Disorders

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study
Tranexamic acid, No Tranexamic acid - Venous Thromboembolism, Venous Thromboses
Phase 4UnknownUniversity Health Network, Toronto202024-06-012024-06-12
A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a Need for Autologous Transplantation
Pentaisomaltose - Malignant Lymphoma, Multiple Myeloma
Phase 4UnknownPharmacosmos A/S1502024-04-302024-04-03
Safety and ASCT-related Symptom Burden Optimization of Tocilizumab in ASCT Following HD Melphalan Conditioning for Multiple Myeloma Patients
Tocilizumab - Multiple Myeloma
Phase 4UnknownThe First Affiliated Hospital of Soochow University482023-04-172023-06-02
Impact of Oxygen Therapy on Fatigue in Patients With Hypermobile-type Ehlers-Danlos Syndrome
Oxygen, Placebo - Ehlers-Danlos Syndrome
Phase 4UnknownHospital St. Joseph, Marseille, France822022-03-102022-03-31
Study of Pomalidomide, Oral Dexamethasone and Ixazomib in Patients With Relapsed MM Who Have Received Lenalidomide
Drug: Ixazomib Drug:pomalidomide Drug:dexamethasone - Multiple Myeloma
Phase 4UnknownPeking Union Medical College Hospital602021-07-262021-08-19
Response to Oral Lansoprazole of Inorganic Pyrophosphate Levels in Patients With Grönblad-Stranberg Disease (Pseudoxanthoma Elasticum)
Lansoprazole 30mg, Placebo - Grönblad-Stranberg Disease (Pseudoxanthoma Elasticum)
Phase 4UnknownFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud202020-02-042020-12-09
A Prospective Study in Chinese Patients With Lower Extremity Ankle Fracture of Oral Anticoagulants to Prevent Venous Thromboembolism (VTE)
Apixaban Oral Tablet - Foot Ankle Injuries, Anticoagulants and Bleeding Disorders
Phase 4UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine10002020-01-012019-11-19
Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention.
Bivalirudin, Heparin - Acute Coronary Syndrome, Percutaneous Coronary Intervention
Phase 4UnknownThe First Affiliated Hospital of Dalian Medical University2402019-07-082019-08-06
RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma
RDD, VDD - Hematologic Neoplasms, Multiple Myeloma
Phase 4UnknownShandong Provincial Hospital1202019-03-302019-11-29
Ulipristal Versus Placebo for Women With Bleeding Induced by Mirena
Ulipristal acetate, Placebo - Heavy Menstrual Bleeding, Abnormal Bleeding
Phase 4UnknownUniversity of Campinas, Brazil322017-07-012018-05-03
PDD vs PAD to Treat Initially Diagnosed MM
PDD regimen: doxorubicin hydrochloride iposome, bortizomib and dexamethasone, PAD regimen: bortizomib, dexamethasone and doxorubicin - Multiple Myeloma
Phase 4UnknownThe First Affiliated Hospital of Soochow University642015-10-012020-02-05
The Effect of Human Albumin on Coagulation Competence and Hemorrhage
5% Human Albumin " Behring", Lactated Ringer - Hemorrhage; Complicating Delivery, Coagulation Defect
Phase 4UnknownKirsten Cleemann Rasmussen402014-08-012014-10-21
A Study of PAD Versus Velcade, Cyclophosphamide and Dexamethasone (VCD) Treatment in Subjects With Multiple Myeloma
PAD, VCD, ASCT - Multiple Myeloma
Phase 4UnknownPeking University People's Hospital502013-05-012013-06-06
Modified Bortezomib-based Combination Therapy for Multiple Myeloma
Bortezomib, Dexamethasone, Doxorubicin - Multiple Myeloma
Phase 4UnknownShanghai General Hospital, Shanghai Jiao Tong University School of Medicine802010-07-012018-05-04
Efficacy Study of PAD and TAD in Newly Diagnosed Multiple Myeloma
Bortezomib,Pirarubicin,Dexamethasone, Thalidomide,Pirarubicin,Dexamethasone - Multiple Myeloma
Phase 4UnknownSecond Military Medical University1002010-06-012010-11-30

Narrower conditions

Multiple Myeloma (8)  ·  Menorrhagia (2)  ·  Venous Thromboembolism (2)  ·  Acute Coronary Syndrome (1)  ·  Ehlers-Danlos Syndrome (1)  ·  Hematologic Neoplasms (1)  ·  Hemorrhage (1)  ·  Lymphoma (1)  ·  Pseudoxanthoma Elasticum (1)  ·  Venous Thrombosis (1)

Broader conditions

Cardiovascular Diseases (15)  ·  Hematologic Diseases (15)  ·  Hemic and Lymphatic Diseases (15)  ·  Hemorrhagic Disorders (15)  ·  Vascular Diseases (15)  ·  Blood Protein Disorders (8)  ·  Immune System Diseases (8)  ·  Immunoproliferative Disorders (8)  ·  Lymphoproliferative Disorders (8)  ·  Neoplasms (8)  ·  Neoplasms by Histologic Type (8)  ·  Neoplasms, Plasma Cell (8)  ·  Paraproteinemias (8)  ·  Pathologic Processes (3)

Interventions

Bortezomib (2)  ·  Dexamethasone (2)  ·  Doxorubicin (2)  ·  Thalidomide (2)  ·  Cyclophosphamide (1)  ·  Heparin (1)  ·  Lansoprazole (1)  ·  Neoadjuvant Therapy (1)  ·  Oxygen (1)  ·  Ringer's Lactate (1)  ·  Serum Albumin, Human (1)  ·  Tranexamic Acid (1)  ·  apixaban (1)  ·  bivalirudin (1)  ·  tocilizumab (1)

Sponsors

The First Affiliated Hospital of Soochow University (2)  ·  Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (1)  ·  Hospital St. Joseph, Marseille, France (1)  ·  Kirsten Cleemann Rasmussen (1)  ·  Peking Union Medical College Hospital (1)  ·  Peking University People's Hospital (1)  ·  Pharmacosmos A/S (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  Second Military Medical University (1)  ·  Shandong Provincial Hospital (1)  ·  Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)  ·  The First Affiliated Hospital of Dalian Medical University (1)  ·  University Health Network, Toronto (1)  ·  University of Campinas, Brazil (1)

Countries

China (9)  ·  Brazil (1)  ·  Denmark (1)  ·  France (1)  ·  Spain (1)

Top investigators

Boris Bienvenu (1)  ·  Guohua Liu, MD (1)  ·  Jian Hou, PhD (1)  ·  Jin Lu, PhD (1)  ·  Junling Zhuang, MD (1)  ·  Niels H Secher, MD PHD Prof (1)  ·  Shaoke Meng, M.D. (1)  ·  Xin Wang, PhD, MD (1)

Results publications

PMID 26945358, PMID 31777949